COMMISSION IMPLEMENTING DECISION (EU) 2023/2883
of 15 December 2023
determining quantitative limits and allocating quotas for substances controlled under Regulation (EC) No 1005/2009 of the European Parliament and of the Council on substances that deplete the ozone layer, for the period 1 January to 31 December 2024
(notified under document C(2023) 8603)
(Only the Bulgarian, Croatian, Czech, Dutch, English, Finnish, French, German, Greek, Hungarian, Irish, Italian, Polish, Portuguese, Spanish and Swedish texts are authentic)
Article 1
Quantitative limits for release for free circulation
Controlled substances |
Quantity (in ozone depleting potential (ODP) kilograms) |
Group I (chlorofluorocarbons 11, 12, 113, 114 and 115) and group II (other fully halogenated chlorofluorocarbons) |
500 550,00 |
Group III (halons) |
26 111 900,00 |
Group IV (carbon tetrachloride) |
2 530 550,00 |
Group V (1,1,1-trichloroethane) |
2 500 000,00 |
Group VI (methyl bromide) |
606 835,20 |
Group VII (hydrobromofluorocarbons) |
9 834,06 |
Group VIII (hydrochlorofluorocarbons) |
5 165 560,80 |
Group IX (bromochloromethane) |
264 024,00 |
Article 2
Allocation of quotas for release for free circulation
Article 3
Quotas for laboratory and analytical uses
Article 4
Period of validity
Article 5
Addressees
1 |
|
2 |
|
||||||||
3 |
|
4 |
|
||||||||
5 |
|
6 |
|
||||||||
7 |
|
8 |
|
||||||||
9 |
|
10 |
|
||||||||
11 |
|
12 |
|
||||||||
13 |
|
14 |
|
||||||||
15 |
|
16 |
|
||||||||
17 |
|
18 |
|
||||||||
19 |
|
20 |
|
||||||||
21 |
|
22 |
|
||||||||
23 |
|
24 |
|
||||||||
25 |
|
26 |
|
||||||||
27 |
|
28 |
|
||||||||
29 |
|
30 |
|
||||||||
31 |
|
32 |
|
||||||||
33 |
|
34 |
|
||||||||
35 |
|
36 |
|
||||||||
37 |
|
38 |
|
||||||||
39 |
|
40 |
|
||||||||
41 |
|
42 |
|
||||||||
43 |
|
44 |
|
||||||||
45 |
|
46 |
|
||||||||
47 |
|
48 |
|
||||||||
49 |
|
50 |
|
||||||||
51 |
|
52 |
|
||||||||
53 |
|
54 |
|
||||||||
55 |
|
56 |
|
||||||||
57 |
|
58 |
|
||||||||
59 |
|
60 |
|
ANNEX I
GROUPS I and II
ANNEX II
GROUP III
ANNEX III
GROUP IV
ANNEX IV
GROUP V
ANNEX V
GROUP VI
ANNEX VI
GROUP VII
ANNEX VII
GROUP VIII
ANNEX VIII
GROUP IX
ANNEX IX
ANNEX X
Undertakings entitled to produce or import for laboratory and analytical uses in 2024
Company Abcr GmbH (DE) |
AGC Pharma Chemicals Europe (ES) |
Agilent Technologies Deutschland GmbH (DE) |
Arkema France (FR) |
Biovit d.o.o. (HR) |
Daikin Refrigerants Frankfurt GmbH (DE) |
GBA Pharma GmbH (DE) |
Gedeon Richter Plc. (HU) |
I2 Analytical Limited sp. z o. o. Oddział w Polsce (PL) |
Labmix24 GmbH (DE) |
LGC GmbH (DE) |
LGC Standards GmbH (DE) |
Neochema GmbH (DE) |
Northern Ireland Environment Agency (UK_NI) |
Restek France (FR) |
Restek GmbH (DE) |
Restek S.r.l. (IT) |
Sigma Aldrich Chimie sarl (FR) |
Sigma-Aldrich Chemie GmbH (DE) |
Solvay Fluor GmbH (DE) |
Solvay France S.A (FR) |
Solvay Specialty Polymers Italy SpA (IT) |
Techlab sarl (FR) |
Ultra Scientific Italia srl (IT) |
Valliscor Europa Limited (IE) |